HomeHome E-mail this pageE-mail this page Print this pagePrint this page
<img border="0" src="images/04subleft.gif" width="474" height="88" alt="The Mark of Individualized Medicine"> monogram biosciences
About Us HIV Products Oncology Products Pharma Partnerships Careers

Contact Us

Products and Services

Archived Webcasts

Pharma Partnerships

GeneSeq® for Entry Inhibitors (HIV Envelope Sequencing) Assay

In addition to the PhenoSense assay for entry inhibitor susceptibility, Monogram has the capability to sequence the HIV envelope (gp160) for clients. This includes V3 Loop, gp41, gp120, or the entire gp160 sequence. The sequence data are provided in customized formats for convenient downloading to clinical databases. Monogram can perform envelope sequencing on virus pools or individual clones. Monogram is investigating the relationships between envelope sequence and phenotypic results and works closely with clients and collaborators to better understand the virus' susceptibility and tropism.

For more information on Monogram assays, services and pricing, please contact us.

Contact Us | Site Map | Privacy Policy | Health Disclaimer | HIPAA Practice | Safe Harbor